| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 26.8K | $55.7K | $2.08 | Jun 13, 2024 | Direct |
| Orchard Therapeutics plc | Director | Stock Option (Right to Buy) | 0 | Jan 24, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| ORTX | Orchard Therapeutics plc | Jan 24, 2024 | 2 | $0 | 4 | Jan 24, 2024 | Director |
| ORTX | Orchard Therapeutics plc | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 7, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| ORTX | Orchard Therapeutics plc | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 29, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |
| ORTX | Orchard Therapeutics plc | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |